tm logo
ISK
Live/Registered
SECTION 71 ACCEPTED

on 22 Mar 2024

Last Applicant/ Owned by

Nishi-Ku, Osaka-Shi

Osaka 550-0002

JP

Serial Number

79186613 filed on 02th Feb 2016

Registration Number

5173581 registered on 04th Apr 2017

in the Principal Register

Correspondent Address

Joseph S. Presta

Nixon & Vanderhye PC

901 N. Glebe Rd.

11th Floor

Arlington,VA 22203

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

ISK

Color is not claimed as a feature of the mark. ISHIHARA SANGYO KAISHA Pharmaceutical preparations for the treatment of Anti-inflammatory, [ anti-shock, ] inflammation of digestive system, [ inflammation of respiratory system, ] anti-pancreatitis, [ pulmonary insufficiency, kidney disease, disseminated intravascular coagulation, chronic obstructive pulmonary disease, pyometra, spondylosis deformaRead More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the treatment of Anti-inflammatory, [ anti-shock, ] inflammation of digestive system, [ inflammation of respiratory system, ] anti-pancreatitis, [ pulmonary insufficiency, kidney disease, disseminated intravascular coagulation, chronic obstructive pulmonary disease, pyometra, spondylosis deformans, systemic inflammatory response syndrome, pneumonia, infectious peritonitis, sepsis, inhibiting thrombogenesis, allergy, tumor metastasis control, infectious disease, encephalitis and surgical stress; ] veterinary preparations for Companion animals, farm animals, dogs [, cats, horses, chickens, cattle and pigs ] for the treatment of Anti-inflammatory, [ anti-shock, ] inflammation of digestive system, [ inflammation of respiratory system, ] anti-pancreatitis, [ pulmonary insufficiency, kidney disease, disseminated intravascular coagulation, chronic obstructive pulmonary disease, pyometra, spondylosis deformans, systemic inflammatory response syndrome, pneumonia, infectious peritonitis, sepsis, inhibiting thrombogenesis, allergy, tumor metastasis control, infectious disease, encephalitis and surgical stress; ] pharameutical agents affecting digestive organs; [ pharmaceutical preparations for skin care for animals; pharmaceutical [ preparations and ] agents, namely, medical test kits composed primarily of reagents and vectors; veterinary preparations and agents, namely, medical test kits composed primarily of reagents and vectors; pharmaceutical preparations and agents, namely, surgical or orthopedic bone cement and medical bone bonding agent; veterinary preparations and agents, namely, surgical or orthopedic bone cement and medical bone bonding agent; ] medicines for veterinary purposes for Companion animals, farm animals, dogs [, cats, horses, chickens, cattle and pigs ] for the treatment of Anti-inflammatory, [ anti-shock, ] inflammation of digestive system, [ inflammation of respiratory system, ] anti-pancreatitis [, pulmonary insufficiency, kidney disease, disseminated intravascular coagulation, chronic obstructive pulmonary disease, pyometra, spondylosis deformans, systemic inflammatory response syndrome, pneumonia, infectious peritonitis, sepsis, inhibiting thrombogenesis, allergy, tumor metastasis control, infectious disease, encephalitis and surgical stress ]

Mark Details


Serial Number

No 79186613

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 1035-1331

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Design Code(s)

26.17.02 -

Wavy line(s), band(s) or bar(s)

26.17.05 -

Horizontal line(s), band(s) or bar(s)

Legal History


Show more

Status DateAction Taken
22nd Mar 2024REGISTERED-SEC.71 ACCEPTED
22nd Mar 2024NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
22nd Feb 2024TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
10th Oct 2023POST REGISTRATION ACTION MAILED - SEC.71
05th Oct 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
15th Mar 2023TEAS SECTION 71 RECEIVED
17th Jun 2022INTERNATIONAL REGISTRATION RENEWED
04th Apr 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
04th Aug 2017FINAL DECISION TRANSACTION PROCESSED BY IB
14th Jul 2017FINAL DISPOSITION PROCESSED